Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

TG103

A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity

CSPC Baike (Shandong) Biopharmaceutical Co · Phase 2 · Completed · Enrollment 314

NCT06226090

ArmPopulationDoseWeeksEstimandWeight change
TG103 7.5 mgObesity or overweight7.5 mg24n/rn/r
Placebo 7.5 mgObesity or overweight7.5 mg24n/rn/r
TG103 15 mgObesity or overweight15 mg24n/rn/r
Placebo 15 mgObesity or overweight15 mg24n/rn/r
TG103 22.5 mgObesity or overweight22.5 mg24n/rn/r
Placebo 22.5 mgObesity or overweight22.5 mg24n/rn/r